Mirati Therapeutics, Inc. (MRTX) Stock Overview
Explore Mirati Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Mirati Therapeutics, Inc. (MRTX)
Key Financials
Key Financials
Market Cap
4.1B
P/E Ratio
-4.46
EPS (TTM)
$-12.18
ROE
-0.62%
MRTX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Mirati Therapeutics, Inc. (MRTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.46 and a market capitalization of 4.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.